Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 112

1.

Striatal reactivity to reward under threat-of-shock and working memory load in adults at increased familial risk for major depression: A preliminary study.

Gaillard C, Guillod M, Ernst M, Federspiel A, Schoebi D, Recabarren RE, Ouyang X, Mueller-Pfeiffer C, Horsch A, Homan P, Wiest R, Hasler G, Martin-Soelch C.

Neuroimage Clin. 2020 Jan 22;26:102193. doi: 10.1016/j.nicl.2020.102193. [Epub ahead of print]

2.

A neuroeconomic investigation of 5-HTT/5-HT1A gene variation, social anxiety, and risk-taking behavior.

Stamatis CA, Engelmann JB, Ziegler C, Domschke K, Hasler G, Timpano KR.

Anxiety Stress Coping. 2020 Mar;33(2):176-192. doi: 10.1080/10615806.2020.1722597. Epub 2020 Feb 3.

PMID:
32009446
3.

Understanding mood in mental disorders.

Hasler G.

World Psychiatry. 2020 Feb;19(1):56-57. doi: 10.1002/wps.20719. No abstract available.

4.

5'UTR polymorphism in the serotonergic receptor HTR3A gene is differently associated with striatal Dopamine D2/D3 receptor availability in the right putamen in Fibromyalgia patients and healthy controls-Preliminary evidence.

Ledermann K, Hasler G, Jenewein J, Sprott H, Schnyder U, Martin-Soelch C.

Synapse. 2019 Dec 23:e22147. doi: 10.1002/syn.22147. [Epub ahead of print]

PMID:
31868947
5.

Striatal responsiveness to reward under threat-of-shock and working memory load: A preliminary study.

Gaillard C, Guillod M, Ernst M, Torrisi S, Federspiel A, Schoebi D, Recabarren RE, Ouyang X, Mueller-Pfeiffer C, Horsch A, Homan P, Wiest R, Hasler G, Martin-Soelch C.

Brain Behav. 2019 Oct;9(10):e01397. doi: 10.1002/brb3.1397. Epub 2019 Sep 26.

6.

Affective cognition in bipolar disorder: A systematic review by the ISBD targeting cognition task force.

Miskowiak KW, Seeberg I, Kjaerstad HL, Burdick KE, Martinez-Aran A, Del Mar Bonnin C, Bowie CR, Carvalho AF, Gallagher P, Hasler G, Lafer B, López-Jaramillo C, Sumiyoshi T, McIntyre RS, Schaffer A, Porter RJ, Purdon S, Torres IJ, Yatham LN, Young AH, Kessing LV, Van Rheenen TE, Vieta E.

Bipolar Disord. 2019 Dec;21(8):686-719. doi: 10.1111/bdi.12834. Epub 2019 Oct 16. Review.

PMID:
31491048
7.

Association between prefrontal glutamine levels and neuroticism determined using proton magnetic resonance spectroscopy.

Hasler G, Buchmann A, Haynes M, Müller ST, Ghisleni C, Brechbühl S, Tuura R.

Transl Psychiatry. 2019 Jun 18;9(1):170. doi: 10.1038/s41398-019-0500-z.

8.

Toward specific ways to combine ketamine and psychotherapy in treating depression.

Hasler G.

CNS Spectr. 2019 Jun 19:1-3. doi: 10.1017/S1092852919001007. [Epub ahead of print]

PMID:
31213212
9.

Chronic Nicotine Exposure Alters Metabotropic Glutamate Receptor 5: Longitudinal PET Study and Behavioural Assessment in Rats.

Müller Herde A, Mihov Y, Krämer SD, Mu L, Adamantidis A, Ametamey SM, Hasler G.

Neurotox Res. 2019 Nov;36(4):806-816. doi: 10.1007/s12640-019-00055-5. Epub 2019 May 22.

PMID:
31119680
10.
11.

Genome-wide association analyses of risk tolerance and risky behaviors in over 1 million individuals identify hundreds of loci and shared genetic influences.

Karlsson Linnér R, Biroli P, Kong E, Meddens SFW, Wedow R, Fontana MA, Lebreton M, Tino SP, Abdellaoui A, Hammerschlag AR, Nivard MG, Okbay A, Rietveld CA, Timshel PN, Trzaskowski M, Vlaming R, Zünd CL, Bao Y, Buzdugan L, Caplin AH, Chen CY, Eibich P, Fontanillas P, Gonzalez JR, Joshi PK, Karhunen V, Kleinman A, Levin RZ, Lill CM, Meddens GA, Muntané G, Sanchez-Roige S, Rooij FJV, Taskesen E, Wu Y, Zhang F; 23and Me Research Team; eQTLgen Consortium; International Cannabis Consortium; Social Science Genetic Association Consortium, Auton A, Boardman JD, Clark DW, Conlin A, Dolan CC, Fischbacher U, Groenen PJF, Harris KM, Hasler G, Hofman A, Ikram MA, Jain S, Karlsson R, Kessler RC, Kooyman M, MacKillop J, Männikkö M, Morcillo-Suarez C, McQueen MB, Schmidt KM, Smart MC, Sutter M, Thurik AR, Uitterlinden AG, White J, Wit H, Yang J, Bertram L, Boomsma DI, Esko T, Fehr E, Hinds DA, Johannesson M, Kumari M, Laibson D, Magnusson PKE, Meyer MN, Navarro A, Palmer AA, Pers TH, Posthuma D, Schunk D, Stein MB, Svento R, Tiemeier H, Timmers PRHJ, Turley P, Ursano RJ, Wagner GG, Wilson JF, Gratten J, Lee JJ, Cesarini D, Benjamin DJ, Koellinger PD, Beauchamp JP.

Nat Genet. 2019 Feb;51(2):245-257. doi: 10.1038/s41588-018-0309-3. Epub 2019 Jan 14.

12.

Cutaneous adverse drug reactions to psychotropic drugs and their risk factors - a case-control study.

Greil W, Zhang X, Stassen H, Grohmann R, Bridler R, Hasler G, Toto S, Bleich S, Kasper S.

Eur Neuropsychopharmacol. 2019 Jan;29(1):111-121. doi: 10.1016/j.euroneuro.2018.10.010. Epub 2018 Nov 10.

13.

Vagus Nerve as Modulator of the Brain-Gut Axis in Psychiatric and Inflammatory Disorders.

Breit S, Kupferberg A, Rogler G, Hasler G.

Front Psychiatry. 2018 Mar 13;9:44. doi: 10.3389/fpsyt.2018.00044. eCollection 2018. Review.

14.

Metabotropic glutamate receptor 5 binding in male patients with alcohol use disorder.

Akkus F, Mihov Y, Treyer V, Ametamey SM, Johayem A, Senn S, Rösner S, Buck A, Hasler G.

Transl Psychiatry. 2018 Jan 10;8(1):17. doi: 10.1038/s41398-017-0066-6.

15.

Fronto-parietal coding of goal-directed actions performed by artificial agents.

Kupferberg A, Iacoboni M, Flanagin V, Huber M, Kasparbauer A, Baumgartner T, Hasler G, Schmidt F, Borst C, Glasauer S.

Hum Brain Mapp. 2018 Mar;39(3):1145-1162. doi: 10.1002/hbm.23905. Epub 2017 Dec 5.

PMID:
29205671
16.

Neural Correlates of Impaired Reward-Effort Integration in Remitted Bulimia Nervosa.

Mueller SV, Morishima Y, Schwab S, Wiest R, Federspiel A, Hasler G.

Neuropsychopharmacology. 2018 Mar;43(4):868-876. doi: 10.1038/npp.2017.277. Epub 2017 Nov 6.

17.

Deep brain stimulation for psychiatric disorders: Is there an impact on social functioning?

Saleh C, Hasler G.

Surg Neurol Int. 2017 Jul 7;8:134. doi: 10.4103/sni.sni_15_17. eCollection 2017. Review.

18.

Neural response to catecholamine depletion in remitted bulimia nervosa: Relation to depression and relapse.

Mueller SV, Mihov Y, Federspiel A, Wiest R, Hasler G.

Eur Neuropsychopharmacol. 2017 Jul;27(7):633-646. doi: 10.1016/j.euroneuro.2017.04.002. Epub 2017 May 11.

19.

Altered Dopamine Responses to Monetary Rewards in Female Fibromyalgia Patients with and without Depression: A [11C]Raclopride Bolus-plus-Infusion PET Study.

Ledermann K, Jenewein J, Sprott H, Hasler G, Schnyder U, Warnock G, Johayem A, Kollias S, Buck A, Martin-Soelch C.

Psychother Psychosom. 2017;86(3):181-182. doi: 10.1159/000455927. Epub 2017 May 11. No abstract available.

20.

Mavoglurant Augmentation in OCD Patients Resistant to Selective Serotonin Reuptake Inhibitors: A Proof-of-Concept, Randomized, Placebo-Controlled, Phase 2 Study.

Rutrick D, Stein DJ, Subramanian G, Smith B, Fava M, Hasler G, Cha JH, Gasparini F, Donchev T, Ocwieja M, Johns D, Gomez-Mancilla B.

Adv Ther. 2017 Feb;34(2):524-541. doi: 10.1007/s12325-016-0468-5. Epub 2017 Jan 2.

PMID:
28044255

Supplemental Content

Loading ...
Support Center